Tech Company Financing Transactions

APT Pharmaceuticals Funding Round

APT Pharmaceuticals secured a $32 million Series B funding round on 9/30/2008. Investors included Three Arch Partners, CLS and Great Point Partners.

Transaction Overview

Company Name
APT Pharmaceuticals
Announced On
9/30/2008
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series B
Investors

Three Arch Partners (Lead Investor) (William Harrington)

CLS (Gino Di Sciullo)

Great Point Partners

InterWest Partners (Nina Kjellson)

Pinnacle Ventures (David Kim)

Versant Ventures (Camille Samuels)

Vivo Capital

Proceeds Purpose
Proceeds from the financing will be used to complete APT's pivotal Phase III program evaluating the safety and efficacy of cyclosporine inhalation solution following lung transplantation. The Series B financing will also fund further development of the company's pipeline programs in serious lung diseases.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
700 Airport Blvd. 350
Burlingame, CA 94010
USA
Phone
(650) 931-1666
Website
www.aptbio.com
Email Address
[email protected]
Overview
APT Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company developing products to treat asthma, chronic pulmonary obstructive disease, rhinitis and rhinovirus.
Profile
APT Pharmaceuticals LinkedIn Company Profile
Social Media
APT Pharmaceuticals Company Twitter Account
Company News
APT Pharmaceuticals News
Facebook
APT Pharmaceuticals on Facebook
YouTube
APT Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Dilly
  Stephen Dilly LinkedIn Profile  Stephen Dilly Twitter Account  Stephen Dilly News  Stephen Dilly on Facebook
Chief Operating Officer
Howie Raff
  Howie Raff LinkedIn Profile  Howie Raff Twitter Account  Howie Raff News  Howie Raff on Facebook
Chief Technical Officer
Ralph Niven
  Ralph Niven LinkedIn Profile  Ralph Niven Twitter Account  Ralph Niven News  Ralph Niven on Facebook
VP - Finance
Joe Melvin
  Joe Melvin LinkedIn Profile  Joe Melvin Twitter Account  Joe Melvin News  Joe Melvin on Facebook
VP - General Counsel
Christina Thomson
  Christina Thomson LinkedIn Profile  Christina Thomson Twitter Account  Christina Thomson News  Christina Thomson on Facebook
VP - Regulatory Affairs
Sue Barrowcliffe
  Sue Barrowcliffe LinkedIn Profile  Sue Barrowcliffe Twitter Account  Sue Barrowcliffe News  Sue Barrowcliffe on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/30/2008: Skyway Software venture capital transaction
Next: 9/30/2008: Envestnet venture capital transaction

 

Share this article

 

Where The Data Comes From

We document funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.